You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – Kantaro Biosciences, a joint venture of Mount Sinai Health System and RenalytixAI, announced on Tuesday that it has entered a marketing a distribution agreement with Atrys Health to distribute Kantaro's SARS-CoV-2 antibody tests.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.